Additional file 1 of Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Authors :: Mercieca-Bebber, R.
Barnes, E. H.
Wilson, K.
Samoon, Z.
Walpole, E.
Mai, T.
Ackland, S.
Burge, M.
Dickie, G.
Watson, D.
Leung, J.
Wang, T.
Bohmer, R.
Cameron, D.
Simes, J.
Gebski, V.
Smithers, M.
Thomas, J.
Zalcberg, J.
Barbour, A. P.
Publication Year :: 2022
Publisher :: figshare, 2022.
Abstract: Additional file 1.

Full Text Access

Tools